Alpha Tau Medical Ltd.

DRTSSEC EDGAR

Surgical & Medical Instruments & Apparatus(L3)CIK: 1871321

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Research and Development Expense	$26.4M	$20.9M	$11.4M	$7.5M	$6.6M
Operating Income (Loss)	-$35.7M	-$32.1M	-$13.8M	-$9.2M	$8.0M
Nonoperating Income (Expense)	$6.5M	-$1.6M	-$13.5M	—	—
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	-$29.1M	-$33.7M	-$27.3M	-$8.7M	$8.3M
Income Tax Expense (Benefit)	$16.0K	$20.0K	$7.0K	$158.0K	-$146.0K
Net Income (Loss) Attributable to Parent	-$29.2M	-$33.8M	-$27.3M	-$8.9M	-$8.4M
Earnings Per Share, Basic	-$0.42	-$0.53	-$0.67	-$0.22	-$0.25
Earnings Per Share, Diluted	-$0.42	-$0.53	-$0.67	-$0.22	-$0.25

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Assets	$86.2M	$107.4M	$120.1M	$42.2M	$53.0M
Assets, Current	$64.2M	$85.8M	$106.5M	$32.6M	$47.5M
Cash and Cash Equivalents, at Carrying Value	$13.7M	$12.7M	$5.8M	$23.2M	$15.6M
Liabilities	$23.5M	$22.9M	$14.5M	$23.0M	$7.5M
Liabilities, Current	$8.7M	$7.1M	$4.3M	$4.4M	$2.1M
Long-term Debt	$20.3K	$20.3K	$20.3K	—	—
Accounts Payable, Current	—	—	$1.4M	$1.2M	$964.0K

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Net Cash Provided by (Used in) Operating Activities	-$18.0M	-$23.9M	-$11.8M	-$7.3M	-$6.9M
Net Cash Provided by (Used in) Investing Activities	$18.7M	-$89.9M	$19.3M	-$7.8M	-$10.2M
Net Cash Provided by (Used in) Financing Activities	$5.3M	$96.9M	$111.0K	$29.3M	$5.3M
Payments to Acquire Property, Plant, and Equipment	$6.4M	$904.0K	$2.9M	$3.8M	$1.3M

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)